Walleye Capital
CEROW

Walleye Capital’s CERo Therapeutics Warrants CEROW Stock Holding History

Walleye Capital’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-156,576
Closed -$799 – 5678
2024
Q3 		$799 Hold
156,576
– – ﹤0.01% 5149
2024
Q2 		$3.15K Buy
156,576
+132,608
+553% +$7.77K ﹤0.01% 5378
2024
Q1 		$1.64K Sell
23,968
-2,050
-8% -$125 ﹤0.01% 5281
2023
Q4 		$611 Hold
26,018
– – ﹤0.01% 4838
2023
Q3 		$1.86K Hold
26,018
– – ﹤0.01% 4722
2023
Q2 		$1.59K Buy
26,018
+100
+0.4% +$4 ﹤0.01% 4170
2023
Q1 		$1.04K Hold
25,918
– – ﹤0.01% 3831
2022
Q4 		$1.12K Buy
+25,918
New +$1.36K ﹤0.01% 3047

Other funds holding CEROW

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Walleye Capital's CEROW Position: Q4 2024 in Review

Walleye Capital sold out of CERo Therapeutics Warrants (CEROW) in Q4 2024, closing a stake of 156,576 shares — an estimated $799 sold.

Walleye Capital first reported a position in CEROW in Q4 2022 and held it in 8 quarters. The position peaked at $3.15K in Q2 2024. 26 funds tracked by Wall St. Rank hold CEROW as of Q4 2024.

  • Walleye Capital reported no remaining CERo Therapeutics Warrants position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 156,576 CERo Therapeutics Warrants shares in Q4 2024, an estimated $799.
  • Walleye Capital first reported a position in CERo Therapeutics Warrants in Q4 2022 and held it in 8 quarters.
  • Walleye Capital's CERo Therapeutics Warrants position peaked at $3.15K in Q2 2024.
  • 26 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.